Ansata Therapeutics Inc.
www.ansatainc.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Ansata Therapeutics Inc.
Drug Delivery: Moving from Platform to Product
The traditional drug-delivery business model of service for hire has fallen from popularity. Big Pharmas are doing few deals of this sort, and investors want bigger returns than fees and royalties can provide. Start-ups with drug delivery technologies are increasingly using their platforms on their own behalf, to create products they can out-license or possibly market themselves. Now content--getting the molecules to be delivered--is an issue.
Selected Start-Ups (1/03)
In Vivo briefly summarizes the technologies of these recently founded companies: Ansata Inc., BioRexis Pharmaceutical Corp., Dentigenix LLC, DermaCo Inc., PhysioGenix Inc. and Zivena Inc.
Company Information
- Industry
-
Pharmaceuticals
-
Drug Delivery
- Topical Delivery
-
Drug Delivery
-
Biotechnology
- Large Molecule
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice